Plasma biomarker screening could improve accuracy, health equity in Alzheimer’s disease diagnosis

A new study focuses on RNA molecules in plasma as biomarkers for Alzheimer's disease in African Americans -- the population at greatest risk for developing Alzheimer's disease. This approach enabled researchers to pinpoint specific molecules in plasma that could serve as biomarkers to confirm a diagnosis of Alzheimer's disease in this population.

from Healthy Aging News -- ScienceDaily https://ift.tt/0BNhufj